Now approved FuturHealth customers can use Affirm's flexible, transparent pay-over-time options to purchase medications, including branded GLP-1 options such as Wegovy and Ozempic, as well as ...

enabling U.S. merchants using Commerce Platform to offer Affirm’s flexible and transparent pay-over-time plans at checkout. This collaboration comes at a time when consumer adoption of Affirm is ...

Now approved FuturHealth customers can use Affirm's flexible, transparent pay-over-time options to purchase medications, including branded GLP-1 options such as Wegovy and Ozempic, as well as ...

Try refreshing your browser, or tap here to see other videos from our team. This collaboration comes at a time when consumer adoption of Affirm is rapidly increasing. More consumers than ever are ...

enabling U.S. merchants using Commerce Platform to offer Affirm's flexible and transparent pay-over-time plans at checkout. This collaboration comes at a time when consumer adoption of Affirm is ...

BMO Capital resumed coverage of Affirm (AFRM) with an Outperform rating and $69 price target The shares are down over 40% from recent highs as investors de-grossed and now contemplate a higher ...

Compass Point analyst Giuliano Bologna last night upgraded Affirm (AFRM) to Buy from Neutral with a price target of $64, up from $61. After Klarna Group (KLAR) announced a partnership with OnePay ...